OVID
Ovid Therapeutics Inc
NASDAQ: OVID · HEALTHCARE · BIOTECHNOLOGY
$2.69
-0.37% today
Updated 2026-04-29
Market cap
$465.47M
P/E ratio
—
P/S ratio
64.19x
EPS (TTM)
$-0.23
Dividend yield
—
52W range
$0 – $3
Volume
3.4M
Ovid Therapeutics Inc (OVID) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $12.62M | $208.38M | $1.50M | $392000.00 | $566000.00 | $7.25M |
| Revenue growth (YoY) | — | — | — | — | — | — | — | +1551.6% | -99.3% | -73.9% | +44.4% | +1181.3% |
| Cost of revenue | $0.00 | $11778.00 | $56512.00 | $80310.00 | $141733.00 | $255000.00 | — | — | $1.38M | $1.60M | $600000.00 | $300000.00 |
| Gross profit | $0.00 | $-11778.00 | $-56512.00 | $-80310.00 | $-141733.00 | $-255000.00 | $12.62M | $208.38M | $1.50M | $392000.00 | $566000.00 | $6.95M |
| Gross margin | — | — | — | — | — | — | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 95.9% |
| R&D | $105375.00 | $6.61M | $9.59M | $49.97M | $33.79M | $42.16M | $63.42M | $46.94M | $24.62M | $28.59M | $36.77M | $25.58M |
| SG&A | $341517.00 | $6.58M | $12.95M | $15.04M | $19.14M | $19.25M | $30.63M | $37.23M | $32.43M | $29.59M | $25.68M | $24.11M |
| Operating income | $-447000.00 | $-13.19M | $-22.54M | $-65.01M | $-52.93M | $-61.41M | $-81.43M | $124.21M | $-55.55M | $-59.28M | $-61.88M | $-42.44M |
| Operating margin | — | — | — | — | — | — | -645.4% | 59.6% | -3696.4% | -15122.7% | -10933.7% | -585.2% |
| EBITDA | $-445000.00 | $-13.18M | $-22.48M | $-64.93M | $-52.79M | $-61.15M | $-81.12M | $124.45M | $-54.17M | $-57.01M | $-57.77M | $-42.14M |
| EBITDA margin | — | — | — | — | — | — | -643.0% | 59.7% | -3604.5% | -14544.1% | -10207.1% | -581.1% |
| EBIT | $-447315.00 | $-13.19M | $-22.54M | $-65.01M | $-52.93M | $-61.41M | $-81.43M | $124.21M | $-55.55M | $-57.58M | $-58.38M | $-42.44M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $46794.00 | $2.76M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-447000.00 | $-13.16M | $-22.41M | $-64.81M | $-51.98M | $-59.26M | $-80.73M | $122.83M | $-51.41M | $-52.34M | $-26.43M | $-17.41M |
| Net income growth (YoY) | — | -2844.1% | -70.3% | -189.1% | +19.8% | -14.0% | -36.2% | +252.2% | -141.9% | -1.8% | +49.5% | +34.1% |
| Profit margin | — | — | — | — | — | — | -639.8% | 58.9% | -3421.0% | -13351.8% | -4670.1% | -240.1% |